Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
81 studies found for:    Open Studies | "lung transplantation"
Show Display Options
Rank Status Study
21 Recruiting Prospective Evaluations of Infectious Complication in Lung Transplant Recipients
Conditions: Disorder Related to Lung Transplantation;   Bronchiolitis Obliterans
Intervention:
22 Recruiting PET Assessment of Acute Lung Transplant Rejection
Condition: Lung Disease
Interventions: Drug: [18F]FDG;   Drug: [18F]ISO-1
23 Recruiting B Cell Induction in Pediatric Lung Transplantation
Condition: Lung Transplant
Interventions: Biological: Rituximab (Rituxan®);   Biological: Placebo
24 Not yet recruiting Confocal Fluorescence Microscopy of the Human Airways in Diagnostics of Lung Transplantation
Condition: Disorder Related to Lung Transplantation
Intervention: Device: Alveoflex Confocal MiniprobeTM
25 Recruiting Self-hypnosis in Patients Awaiting Lung Transplantation
Condition: Lung Transplantation
Interventions: Behavioral: Self-hypnosis;   Behavioral: Routine practice
26 Not yet recruiting Macitentan in the Treatment of Organ Rejection After Lung Transplantation
Condition: Lung Transplant Rejection
Interventions: Drug: macitentan;   Drug: placebo (for macitentan)
27 Recruiting Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation
Condition: Lung Transplant Rejection
Intervention: Drug: Carfilzomib
28 Recruiting Preliminary Study of Dornase Alpha to Treat Chest Infections Post Lung Transplant.
Conditions: Lung Transplant Infection;   Lower Respiratory Tract Infection.
Interventions: Drug: Dornase Alpha;   Drug: Isotonic Saline.
29 Recruiting Study to Evaluate the Safety and Efficacy of Intravenous Glassia® Treatment in Lung Transplantation
Condition: Transplantation, Lung Rejection
Intervention: Drug: GLASSIA® and Institution standard of care (SOC)
30 Recruiting Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant
Condition: Primary Graft Dysfunction
Intervention:
31 Recruiting Predictive Value of PIIINP Urinary for the Development of Chronic Renal Failure in Patients With Cystic Fibrosis After Lung Transplantation (MUCO-IRC)
Conditions: Lung Transplantation;   Cystic Fibrosis;   Renal Failure
Intervention: Biological: Urinary levels of PIIINP as a marker of changes in renal function
32 Recruiting Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans;   Constructive Bronchiolitis;   Graft Versus Host Disease
Intervention: Drug: Inhaled Cyclosporine Solution
33 Recruiting Presatovir in Lung Transplant (LT) Recipients With Respiratory Syncytial Virus (RSV) Infection
Condition: Respiratory Syncytial Virus (RSV)
Interventions: Drug: Presatovir;   Drug: Placebo
34 Unknown  Generic Immunosuppressive Drugs After Lung Transplantation
Condition: Immunosuppressive After Lung Transplantation
Intervention: Other: patient questionnaire (tablet pc based)
35 Not yet recruiting VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation
Condition: End Stage Chronic Obstructive Airways Disease
Intervention:
36 Not yet recruiting Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation
Conditions: Cystic Fibrosis;   Lungtransplantation;   Paranasal Sinus Diseases
Intervention: Other: Bronchoalveolar and Nasal Lavage
37 Recruiting Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases
Conditions: Severe Combined Immunodeficiency (SCID);   Immunodeficiency With Predominant T-cell Defect, Unspecified;   Severe Chronic Neutropenia;   Chronic Granulomatous Disease (CGD);   Hyper IgE Syndromes;   Hyper IgM Deficiencies;   Wiskott-Aldrich Syndrome;   Mendelian Susceptibility to Mycobacterial Disease;   Common Variable Immune Deficiency (CVID)
Intervention: Biological: CD3/CD19 negative allogeneic hematopoietic stem cells
38 Unknown  Pulmonary Rehabilitation and Inspiratory Muscle Training (IMT) for Patients Following Lung Transplantation
Condition: Lung Transplantation
Interventions: Behavioral: Conventional or regular pulmonary rehabilitation program alone;   Device: very low load IMT (sham IMT) alone;   Device: Conventional or regular pulmonary rehabilitation program + targeted inspiratory resistive or threshold IMT;   Device: Targeted inspiratory resistive or threshold IMT alone
39 Not yet recruiting Study to Evaluate the Value of the Follow-up of CALCIneurin Activity to MOdulate Calcineurin Inhibitors-induced Immunosuppression in Lung Transplantation
Condition: Lung Diseases
Interventions: Biological: levels of CNI in whole blood;   Biological: Calcineurin activity (CN-a) in peripheral blood mononuclear cells (PBMCs)
40 Not yet recruiting OPTIMIZATION OF NUTRITIONAL MANAGEMENT OF PATIENTS WAITING FOR LUNG TRANSPLANT INTO Strasbourg University Hospitals
Condition: Malnutrition
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years